ANGEL LUIS
GUERRERO PERAL
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Universitat Autònoma de Barcelona (9)
2022
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
-
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients
Cephalalgia, Vol. 42, Núm. 8, pp. 804-809
2021
-
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
Journal of Headache and Pain, Vol. 22, Núm. 1
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
-
Persistent headache after COVID-19: Pathophysioloy, clinic and treatment
Neurology Perspectives, Vol. 1, pp. S31-S36
2020
-
Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study
European Journal of Neurology, Vol. 27, Núm. 10, pp. 2102-2108
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
-
Specialised headache units, a feasible alternative in Spain
Revista de Neurologia, Vol. 71, Núm. 6, pp. 199-204
2019
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417